15 results on '"Viacheslav Nikolaev"'
Search Results
2. How Carvedilol activates β2-adrenoceptors
- Author
-
Tobias Benkel, Mirjam Zimmermann, Julian Zeiner, Sergi Bravo, Nicole Merten, Victor Jun Yu Lim, Edda Sofie Fabienne Matthees, Julia Drube, Elke Miess-Tanneberg, Daniela Malan, Martyna Szpakowska, Stefania Monteleone, Jak Grimes, Zsombor Koszegi, Yann Lanoiselée, Shannon O’Brien, Nikoleta Pavlaki, Nadine Dobberstein, Asuka Inoue, Viacheslav Nikolaev, Davide Calebiro, Andy Chevigné, Philipp Sasse, Stefan Schulz, Carsten Hoffmann, Peter Kolb, Maria Waldhoer, Katharina Simon, Jesus Gomeza, and Evi Kostenis
- Subjects
Science - Abstract
Abstract Carvedilol is among the most effective β-blockers for improving survival after myocardial infarction. Yet the mechanisms by which carvedilol achieves this superior clinical profile are still unclear. Beyond blockade of β1-adrenoceptors, arrestin-biased signalling via β2-adrenoceptors is a molecular mechanism proposed to explain the survival benefits. Here, we offer an alternative mechanism to rationalize carvedilol’s cellular signalling. Using primary and immortalized cells genome-edited by CRISPR/Cas9 to lack either G proteins or arrestins; and combining biological, biochemical, and signalling assays with molecular dynamics simulations, we demonstrate that G proteins drive all detectable carvedilol signalling through β2ARs. Because a clear understanding of how drugs act is imperative to data interpretation in basic and clinical research, to the stratification of clinical trials or to the monitoring of drug effects on the target pathway, the mechanistic insight gained here provides a foundation for the rational development of signalling prototypes that target the β-adrenoceptor system.
- Published
- 2022
- Full Text
- View/download PDF
3. Establishing a sensitive fluorescence-based quantification method for cyclic nucleotides
- Author
-
Nadine Gruteser, Viktoria Kohlhas, Sabine Balfanz, Arne Franzen, Anne Günther, Andreas Offenhäusser, Frank Müller, Viacheslav Nikolaev, Martin J. Lohse, and Arnd Baumann
- Subjects
Cyclic nucleotide quantification ,Cell-based assay ,Epac1-camps ,Optogenetic sensor ,Signaling ,Biotechnology ,TP248.13-248.65 - Abstract
Abstract Background Approximately 40% of prescribed drugs exert their activity via GTP-binding protein-coupled receptors (GPCRs). Once activated, these receptors cause transient changes in the concentration of second messengers, e.g., cyclic adenosine 3′,5′-monophosphate (cAMP). Specific and efficacious genetically encoded biosensors have been developed to monitor cAMP fluctuations with high spatial and temporal resolution in living cells or tissue. A well characterized biosensor for cAMP is the Förster resonance energy transfer (FRET)-based Epac1-camps protein. Pharmacological characterization of newly developed ligands acting at GPCRs often includes numerical quantification of the second messenger amount that was produced. Results To quantify cellular cAMP concentrations, we bacterially over-expressed and purified Epac1-camps and applied the purified protein in a cell-free detection assay for cAMP in a multi-well format. We found that the biosensor can detect as little as 0.15 pmol of cAMP, and that the sensitivity is not impaired by non-physiological salt concentrations or pH values. Notably, the assay tolerated desiccation and storage of the protein without affecting Epac1-camps cyclic nucleotide sensitivity. Conclusions We found that determination cAMP in lysates obtained from cell assays or tissue samples by purified Epac1-camps is a robust, fast, and sensitive assay suitable for routine and high throughput analyses.
- Published
- 2020
- Full Text
- View/download PDF
4. Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture
- Author
-
Maria Faleeva, Ivan Diakonov, Prashant Srivastava, Masoud Ramuz, Gaia Calamera, Kjetil Wessel Andressen, Nadja Bork, Lorenza Tsansizi, Marie-Victoire Cosson, Andreia Sofia Bernardo, Viacheslav Nikolaev, and Julia Gorelik
- Subjects
cGMP ,phosphodiesterase ,stem cells ,cardiomyocytes ,FRET ,Cytology ,QH573-671 - Abstract
The therapeutic benefit of stimulating the cGMP pathway as a form of treatment to combat heart failure, as well as other fibrotic pathologies, has become well established. However, the development and signal compartmentation of this crucial pathway has so far been overlooked. We studied how the three main cGMP pathways, namely, nitric oxide (NO)-cGMP, natriuretic peptide (NP)-cGMP, and β3-adrenoreceptor (AR)-cGMP, mature over time in culture during cardiomyocyte differentiation from human pluripotent stem cells (hPSC-CMs). After introducing a cGMP sensor for Förster Resonance Energy Transfer (FRET) microscopy, we used selective phosphodiesterase (PDE) inhibition to reveal cGMP signal compartmentation in hPSC-CMs at various times of culture. Methyl-β-cyclodextrin was employed to remove cholesterol and thus to destroy caveolae in these cells, where physical cGMP signaling compartmentalization is known to occur in adult cardiomyocytes. We identified PDE3 as regulator of both the NO-cGMP and NP-cGMP pathway in the early stages of culture. At the late stage, the role of the NO-cGMP pathway diminished, and it was predominantly regulated by PDE1, PDE2, and PDE5. The NP-cGMP pathway shows unrestricted locally and unregulated cGMP signaling. Lastly, we observed that maturation of the β3-AR-cGMP pathway in prolonged cultures of hPSC-CMs depends on the accumulation of caveolae. Overall, this study highlighted the importance of structural development for the necessary compartmentation of the cGMP pathway in maturing hPSC-CMs.
- Published
- 2022
- Full Text
- View/download PDF
5. Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6.
- Author
-
Caroline Bull Melsom, Marie-Victoire Cosson, Øivind Ørstavik, Ngai Chin Lai, H Kirk Hammond, Jan-Bjørn Osnes, Tor Skomedal, Viacheslav Nikolaev, Finn Olav Levy, and Kurt Allen Krobert
- Subjects
Medicine ,Science - Abstract
PurposeWe previously reported that inhibitory G protein (Gi) exerts intrinsic receptor-independent inhibitory activity upon adenylyl cyclase (AC) that regulates contractile force in rat ventricle. The two major subtypes of AC in the heart are AC5 and AC6. The aim of this study was to determine if this intrinsic Gi inhibition regulating contractile force is AC subtype selective.MethodsWild-type (WT), AC5 knockout (AC5KO) and AC6 knockout (AC6KO) mice were injected with pertussis toxin (PTX) to inactivate Gi or saline (control).Three days after injection, we evaluated the effect of simultaneous inhibition of phosphodiesterases (PDE) 3 and 4 with cilostamide and rolipram respectively upon in vivo and ex vivo left ventricular (LV) contractile function. Also, changes in the level of cAMP were measured in left ventricular homogenates and at the membrane surface in cardiomyocytes obtained from the same mouse strains expressing the cAMP sensor pmEPAC1 using fluorescence resonance energy transfer (FRET).ResultsSimultaneous PDE3 and PDE4 inhibition increased in vivo and ex vivo rate of LV contractility only in PTX-treated WT and AC5KO mice but not in saline-treated controls. Likewise, Simultaneous PDE3 and PDE4 inhibition elevated total cAMP levels in PTX-treated WT and AC5KO mice compared to saline-treated controls. In contrast, simultaneous PDE3 and PDE4 inhibition did not increase in vivo or ex vivo rate of LV contractility or cAMP levels in PTX-treated AC6KO mice compared to saline-treated controls. Using FRET analysis, an increase of cAMP level was detected at the membrane of cardiomyocytes after simultaneous PDE3 and PDE4 inhibition in WT and AC5KO but not AC6KO. These FRET data are consistent with the functional data indicating that AC6 activity and PTX inhibition of Gi is necessary for simultaneous inhibition of PDE3 and PDE4 to elicit an increase in contractility.ConclusionsTogether, these data suggest that AC6 is tightly regulated by intrinsic receptor-independent Gi activity, thus providing a mechanism for maintaining low basal cAMP levels in the functional compartment that regulates contractility.
- Published
- 2019
- Full Text
- View/download PDF
6. Acute Modulation of Left Ventricular Control by Selective Intracardiac Sympathetic Denervation
- Author
-
Ann-Kathrin Kahle, Niklas Klatt, Christiane Jungen, Aaron Dietenberger, Pawel Kuklik, Paula Münkler, Stephan Willems, Viacheslav Nikolaev, Dainius H. Pauza, Katharina Scherschel, and Christian Meyer
- Published
- 2023
- Full Text
- View/download PDF
7. A-Kinase Anchoring Proteins in Cardiac Myocytes and Their Roles in Regulating Calcium Cycling
- Author
-
Viacheslav Nikolaev and Hariharan Subramanian
- Subjects
General Medicine - Abstract
The rate of calcium cycling and calcium transient amplitude are critical determinants for the efficient contraction and relaxation of the heart. Calcium-handling proteins in the cardiac myocyte are altered in heart failure, and restoring the proper function of those proteins is an effective potential therapeutic strategy. The calcium-handling proteins or their regulators are phosphorylated by a cAMP-dependent kinase (PKA), and thereby their activity is regulated. A-Kinase Anchoring Proteins (AKAPs) play a seminal role in orchestrating PKA and cAMP regulators in calcium handling and contractile machinery. This cAMP/PKA orchestration is crucial for the increased force and rate of contraction and relaxation of the heart in response to fight-or-flight. Knockout models and the few available preclinical models proved that the efficient targeting of AKAPs offers potential therapies tailor-made for improving defective calcium cycling. In this review, we highlight important studies that identified AKAPs and their regulatory roles in cardiac myocyte calcium cycling in health and disease.
- Published
- 2023
- Full Text
- View/download PDF
8. Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes
- Author
-
Ping Lai, Viacheslav Nikolaev, and Kirstie De Jong
- Subjects
Cardiology and Cardiovascular Medicine ,Molecular Biology - Published
- 2022
- Full Text
- View/download PDF
9. Role of PDEs in receptor-microdomain communication in a patient-specific Takotsubo stem cell model
- Author
-
Daniela Hübscher, Gideon Syed-Ali, Gerd Hasenfuss, Viacheslav Nikolaev, and Katrin Streckfuss-Bömeke
- Subjects
Cardiology and Cardiovascular Medicine ,Molecular Biology - Published
- 2022
- Full Text
- View/download PDF
10. Microdomains in the Cardiovascular System
- Author
-
Viacheslav Nikolaev, Manuela Zaccolo, Viacheslav Nikolaev, and Manuela Zaccolo
- Subjects
- Pharmacology, Cardiology, Cytology, Cardiovascular system--Physiology, Cardiovascular system--Molecular aspects, Human physiology
- Abstract
The book comprehensively presents new findings in cardiovascular research related to signaling microdomains in health and disease. Important second messengers such as cAMP, cGMP, calcium and their role in microdomain signaling are discussed. The book offers and explains methodical approaches and technical ways how to successfully analyze microdomain signaling, also in the context of disease. It further provides scientific perspectives and strategies that are based on the concept of signaling within microdomains and that can revolutionize pharmacology and eventually lead to the effective treatment of cardiovascular diseases in future.This book is written for scientists in cardiovascular research, pharmacology, molecular and cellular biology as well as medical doctors in cardiology, angiology and nephrology.
- Published
- 2017
11. Functional Non-Nucleoside Adenylyl Cyclase Inhibitors
- Author
-
Manfred Wagner, Viacheslav Nikolaev, Stefka Kaloyanova, Kalina Peneva, Abdul Hameed, Marco Lelle, Filip Berisha, and Lisa-Maria Ackermann
- Subjects
Pharmacology ,chemistry.chemical_classification ,Bioconjugation ,Endosome ,Organic Chemistry ,ADCY9 ,HEK 293 cells ,Isoproterenol ,Peptide ,Biosensing Techniques ,Cell-Penetrating Peptides ,Biochemistry ,Adenylyl Cyclase Inhibitors ,HEK293 Cells ,Förster resonance energy transfer ,chemistry ,Drug Discovery ,Cyclic AMP ,Fluorescence Resonance Energy Transfer ,Humans ,Molecular Medicine ,Nucleoside ,Adenylyl Cyclases - Abstract
In this study, we describe the synthesis of novel functional non-nucleoside adenylyl cyclase inhibitors, which can be easily modified with thiol containing biomolecules such as tumour targeting structures. The linkage between inhibitor and biomolecule contains cleavable bonds to enable efficient intracellular delivery in the reductive milieu of the cytosol as well as in the acidic environment within endosomes and lysosomes. The suitability of this synthetic approach was shown by the successful bioconjugation of a poor cell-permeable inhibitor with a cell-penetrating peptide. Additionally, we have demonstrated the excellent inhibitory effect of the compounds presented here in a live-cell Förster resonance energy transfer-based assay in human embryonic kidney cells.
- Published
- 2014
- Full Text
- View/download PDF
12. Role of Membrane Microdomains in Compartmentation of cAMP Signaling
- Author
-
Cherie A. Singer, Martin J. Lohse, Monica Rice, Viacheslav Nikolaev, Colleen E. Clancy, Shailesh R. Agarwal, Robert D. Harvey, Pei Chi Yang, and Kanzaki, Makoto
- Subjects
Cell signaling ,Cell Membranes ,lcsh:Medicine ,Biosensing Techniques ,Signal transduction ,Biochemistry ,Adenylyl cyclase ,chemistry.chemical_compound ,0302 clinical medicine ,Molecular Cell Biology ,Biochemical Simulations ,Cyclic AMP ,Membrane Technology ,lcsh:Science ,Lipid raft ,0303 health sciences ,Multidisciplinary ,Membrane ,Microdomains ,cAMP Signaling ,Systems Biology ,Phosphodiesterase ,Signaling cascades ,Raft ,cAMP signaling cascade ,Cell biology ,Cholesterol ,Beta-2 adrenergic receptor ,Engineering and Technology ,lipids (amino acids, peptides, and proteins) ,Cellular Structures and Organelles ,Network Analysis ,Signal Transduction ,Research Article ,Computer Modeling ,Biophysical Simulations ,Cell Physiology ,Computer and Information Sciences ,General Science & Technology ,Phosphodiesterase 3 ,Biophysics ,Biology ,ADCY10 ,Membrane Structures ,Cell Line ,03 medical and health sciences ,Membrane Microdomains ,Humans ,ddc:610 ,030304 developmental biology ,Biology and life sciences ,lcsh:R ,Computational Biology ,Signaling Networks ,chemistry ,Membrane Trafficking ,lcsh:Q ,030217 neurology & neurosurgery - Abstract
Spatially restricting cAMP production to discrete subcellular locations permits selective regulation of specific functional responses. But exactly where and how cAMP signaling is confined is not fully understood. Different receptors and adenylyl cyclase isoforms responsible for cAMP production are not uniformly distributed between lipid raft and non-lipid raft domains of the plasma membrane. We sought to determine the role that these membrane domains play in organizing cAMP responses in HEK293 cells. The freely diffusible FRET-based biosensor Epac2-camps was used to measure global cAMP responses, while versions of the probe targeted to lipid raft (Epac2-MyrPalm) and non-raft (Epac2-CAAX) domains were used to monitor local cAMP production near the plasma membrane. Disruption of lipid rafts by cholesterol depletion selectively altered cAMP responses produced by raft-associated receptors. The results indicate that receptors associated with lipid raft as well as non-lipid raft domains can contribute to global cAMP responses. In addition, basal cAMP activity was found to be significantly higher in non-raft domains. This was supported by the fact that pharmacologic inhibition of adenylyl cyclase activity reduced basal cAMP activity detected by Epac2-CAAX but not Epac2-MyrPalm or Epac2-camps. Responses detected by Epac2-CAAX were also more sensitive to direct stimulation of adenylyl cyclase activity, but less sensitive to inhibition of phosphodiesterase activity. Quantitative modeling was used to demonstrate that differences in adenylyl cyclase and phosphodiesterase activities are necessary but not sufficient to explain compartmentation of cAMP associated with different microdomains of the plasma membrane. peerReviewed
- Published
- 2014
13. Abstract 194: Phosphodiesterase 3 Controls Basal cGMP Levels And Regulates cGMP/cAMP Cross-talk In Adult Mouse Ventricular Cardiomyocytes
- Author
-
Konrad Götz and Viacheslav Nikolaev
- Subjects
Physiology ,Cardiology and Cardiovascular Medicine - Abstract
PURPOSE: cGMP is an important second messenger which is involved in the regulation of cardiac contractility and pathological hypertrophy. In cardiomyocytes, signaling by cGMP is organized in microdomains and is considered cardioprotective. Especially in adult cardiac myocytes, measurements of cGMP have been challenging and little is known about the spatio-temporal dynamics of cGMP. Here we developed a transgenic mouse model to visualize cGMP dynamis in adult cardiac myocytes. Methods: We generated transgenic mice with cardiomyocyte-specific expression of a highly sensitive fluorescence resonance energy transfer (FRET)-based cGMP biosensor red cGES-DE5 and performed FRET measurements in freshly isolated adult mouse ventricular myocytes. To analyze cGMP/cAMP crosstalk, FRET experiments were performed in cardiomyocytes isolated from mice transgenically expressing the cAMP sensor Epac1-camps. Results: Basal cytosolic cGMP levels were very low (~10 nM), but could be markedly increased by stimulation with natriuretic peptides (CNP>>ANP). In contrast, direct stimulation of the soluble guanylyl cyclase (sGC) with NO-donors such as SNAP showed no effect. However, constitutive activity of this cyclase contributes to basal cGMP production, since a clear decrease of basal cGMP levels was observed after stimulation with the sGC inhibitor ODQ. This basal cGMP production is regulated by phosphodiesterase (PDE) activity. Unexpectedly, PDE3 is most important in controlling basal cGMP levels, whereas PDE2 and PDE5 are much less active. We could also show that cGMP pools produced by GC-B after CNP stimulation are mainly regulated by PDE3, so that the receptor and this PDE form one functional unit important for the regulation of cGMP/cAMP cross-talk. Conclusion: In summary, we performed the first FRET-based measurements of cGMP in adult cardiomyocytes and we could highlight the key role of PDE3 in the regulation of basal cGMP levels and cGMP/cAMP cross-talk.
- Published
- 2013
- Full Text
- View/download PDF
14. Interfering Influence of Native German Dialects on the Language of Non-native Dialect Environment: Russian Speech of the German Bilinguals
- Author
-
Olga Vladimirovna Baykova, Andrey Viktorovich Kazakov, Vladimir Alexandrovich Banin, Olga Nikolayevna Obukhova, Yilia Valeryevna Berezina, and Viacheslav Nikolaevich Onoshko
- Subjects
Russian Germans of the Kirov Region, Native German Dialects on the Language of Non-native Dialect Environment, Russian Speech of the German Bilinguals, Interference at all Levels of the Language, Mixing of Languages ,Ethnology. Social and cultural anthropology ,GN301-674 - Abstract
The problem of interference is one of the most complex issues related to language interaction, so it is especially important to investigate its workings on the example of the language of Russian Germans in the Kirov region. The article realises the historical and linguocultural approaches to the study of the interrelationship between folk-colloquial speech and the traditional culture of Russian Germans, residing on the territory of the Kirov region. The authors present the results of an in-depth analysis of interference features in the Russian speech of German bilinguals under the influence of the German language and its dialects, namely, the phonetic, lexical and grammatical features that occur under the influence of interference with the German language. The Russian speech of German bilinguals is heterogeneous and varies from "virtually without an accent" to "unnatural" for Russian monolingual hearing. The interaction of the Russian and German languages in the speech of German bilinguals resulted in the increased invasion of the norms of one language system into the framework of another language. This leads to the so-called levelling of the interacting languages. In other words, we see the emergence of a third–intermediate system that does not coincide either with the German or Russian languages and performs in the bilingual consciousness an adaptive function to the environment language. This study contributes to German dialectology, enriching both the theory and typology of island dialects, which retain archaic features and the theory and practice of scientifically grounded language policy and language preservation.
- Published
- 2018
- Full Text
- View/download PDF
15. Cyclic Nucleotide Phosphodiesterases and Compartmentation in Normal and Diseased Heart
- Author
-
Rodolphe Fischmeister, Pierre Bobin, Grégoire Vandecasteele, Ibrahim Bedioune, Jérôme Leroy, Signalisation et physiopathologie cardiovasculaire (UMRS1180), Institut National de la Santé et de la Recherche Médicale (INSERM), Signalisation et physiopathologie cardiaque, Université Paris-Sud - Paris 11 (UP11)-IFR141-Institut National de la Santé et de la Recherche Médicale (INSERM), Viacheslav Nikolaev, and Manuela Zaccolo
- Subjects
0301 basic medicine ,Cardiac function curve ,cyclic nucleotide phosphodiesterases ,Phosphodiesterase 3 ,heart failure ,Vasodilation ,030204 cardiovascular system & hematology ,Biology ,PDE1 ,medicine.disease ,Cell biology ,cGMP ,03 medical and health sciences ,Cyclic nucleotide ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,chemistry ,Biochemistry ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Heart failure ,cAMP ,Second messenger system ,medicine ,Heart failure with preserved ejection fraction - Abstract
International audience; Cyclic nucleotide phosphodiesterases (PDEs) degrade the second messengers cAMP and cGMP, thereby regulating multiple aspects of cardiac function. This highly diverse class of enzymes encoded by 21 genes encompasses 11 families which are not only responsible for the termination of cyclic nucleotide signalling, but are also involved in the generation of dynamic microdomains of cAMP and cGMP controlling specific cell functions in response to various neurohormonal stimuli. In myocardium, the PDE3 and PDE4 families are predominant to degrade cAMP and thereby regulate cardiac excitation-contraction coupling. PDE3 inhibitors are positive inotropes and vasodilators in human, but their use is limited to acute heart failure and intermittent claudication. PDE5 is particularly important to degrade cGMP in vascular smooth muscle, and PDE5 inhibitors are used to treat erectile dysfunction and pulmonary hypertension. However, these drugs do not seem efficient in heart failure with preserved ejection fraction. There is experimental evidence that these PDEs as well as other PDE families including PDE1, PDE2 and PDE9 may play important roles in cardiac diseases such as hypertrophy and heart failure. After a brief presentation of the cyclic nucleotide pathways in cardiac cells and the major characteristics of the PDE superfamily, this chapter will present their role in cyclic nucleotide compartmentation and the current use of PDE inhibitors in cardiac diseases together with the recent research progresses that could lead to a better exploitation of the therapeutic potential of these enzymes in the future.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.